Pelthos Therapeutics PTHS
NYSE PTHS
$9.34 +0.44 (+4.94%)
As of: Nov 11, 2026 · 3:59 PM EST

Pelthos Therapeutics (PTHS) Depreciation and Depletion (2025 - 2026)

Updated

Pelthos Therapeutics (PTHS) recorded Depreciation and Depletion of $278,000 in Q2 2026, down 40.7% from the prior quarter.

Analysis

Pelthos Therapeutics (PTHS) Depreciation and Depletion (2025 - 2026) Analysis & Trends

On a TTM basis, Pelthos Therapeutics' Depreciation and Depletion came in at $1.48 million as of Jun 30, 2026; for FY2025, it was $729,000.

  • Quarterly Depreciation and Depletion has ranged from $74,000 in Q3 2025 to $655,000 in Q4 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $469,000 (Q1 2026), $655,000 (Q4 2025) and $74,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Pelthos Therapeutics 33.36 Mn -55.04 Mn 11.99 Mn 278,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 278,000.00
Mar 31, 2026 469,000.00
Dec 31, 2025 340,000.00
Sep 30, 2025 389,000.00
API Access

Pelthos Therapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=PTHS&period=max&api_key=YOUR_API_KEY